Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Ksander

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Current Eye Research|January 20, 2006
Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccinesPeter W Chen, Bruce R Ksander
Chemical Immunology and Allergy|February 1, 2007
Influence of immune surveillance and immune privilege on formation of intraocular tumorsPeter W Chen, Bruce R Ksander
Experimental Eye Research|April 29, 2006
Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilegePeter W Chen, Tohishiko Uno, Bruce R Ksander
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Tumor escape mutants develop within an immune-privileged environment in the absence of T cell selectionPeter W Chen, Toshihiko Uno, Bruce R Ksander
Infection and Immunity|April 10, 2013
Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearanceNorito Sugi, Emily A Whiston, Bruce R Ksander, et al.
Expert Opinion on Biological Therapy|February 24, 2018
Repairing the corneal epithelium using limbal stem cells or alternative cell-based therapiesYuzuru Sasamoto, Bruce R Ksander, Markus H Frank, et al.
Research Square|May 20, 2024
Fas Ligand enhances vessel maturation and inhibits vascular leakage associated with age-related macular degenerationAdarsha Koirala, Ann Marshak-Rothstein, Bruce R Ksander, et al.
Frontiers in Molecular Neuroscience|June 7, 2014
Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaEmmanuel S Buys, Lincoln R Potter, Louis R Pasquale, et al.
Cancer Research|December 20, 2007
Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligandMeredith S Gregory, Rebecca R Saff, Ann Marshak-Rothstein, et al.
Experimental Eye Research|October 27, 2018
Soluble Fas ligand blocks destructive corneal inflammation in mouse models of corneal epithelial debridement and LPS induced keratitisMeredith Gregory-Ksander, Victor L Perez, Ann Marshak-Rothstein, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Current Eye Research|January 20, 2006
Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccinesPeter W Chen, Bruce R Ksander
Chemical Immunology and Allergy|February 1, 2007
Influence of immune surveillance and immune privilege on formation of intraocular tumorsPeter W Chen, Bruce R Ksander
Experimental Eye Research|April 29, 2006
Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilegePeter W Chen, Tohishiko Uno, Bruce R Ksander
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Tumor escape mutants develop within an immune-privileged environment in the absence of T cell selectionPeter W Chen, Toshihiko Uno, Bruce R Ksander
Infection and Immunity|April 10, 2013
Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearanceNorito Sugi, Emily A Whiston, Bruce R Ksander, et al.
Expert Opinion on Biological Therapy|February 24, 2018
Repairing the corneal epithelium using limbal stem cells or alternative cell-based therapiesYuzuru Sasamoto, Bruce R Ksander, Markus H Frank, et al.
Research Square|May 20, 2024
Fas Ligand enhances vessel maturation and inhibits vascular leakage associated with age-related macular degenerationAdarsha Koirala, Ann Marshak-Rothstein, Bruce R Ksander, et al.
Frontiers in Molecular Neuroscience|June 7, 2014
Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaEmmanuel S Buys, Lincoln R Potter, Louis R Pasquale, et al.
Cancer Research|December 20, 2007
Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligandMeredith S Gregory, Rebecca R Saff, Ann Marshak-Rothstein, et al.
Experimental Eye Research|October 27, 2018
Soluble Fas ligand blocks destructive corneal inflammation in mouse models of corneal epithelial debridement and LPS induced keratitisMeredith Gregory-Ksander, Victor L Perez, Ann Marshak-Rothstein, et al.
Pageof 7